Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) has shared an update.
ResMed Inc. has reported a change in beneficial ownership, with Director Desney Tan acquiring 1,073 shares of ResMed common stock through Restricted Stock Units (RSUs). These RSUs are set to vest fully by November 11, 2026, or at the next annual stockholder meeting, indicating a strategic move to align management interests with shareholder value, potentially impacting investor confidence positively.
The most recent analyst rating on (AU:RMD) stock is a Buy with a A$42.00 price target. To see the full list of analyst forecasts on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh stock, see the AU:RMD Stock Forecast page.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
ResMed Inc. operates in the healthcare industry, focusing primarily on the development and manufacturing of equipment related to sleep disorders, respiratory care, and connected health solutions. The company is known for its innovative products that enhance the quality of life for patients with sleep apnea and other chronic respiratory conditions.
Average Trading Volume: 1,214,271
Technical Sentiment Signal: Buy
Current Market Cap: A$56.69B
See more insights into RMD stock on TipRanks’ Stock Analysis page.